Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: Toxicon. 2014 Jun 17;0:93–98. doi: 10.1016/j.toxicon.2014.06.012

Figure 5.

Figure 5

Therapeutic use of ETX MAb c4D7 in mice challenged with 30 LD50 of ETX ip. 10× the ED100 protective dose of ETX MAb c4D7 was given to mice (n=8) at 15, 30, 45 or 60 minutes after ETX challenge.